Literature DB >> 25674278

Ovarian malignant mixed germ cell tumor with clear cell carcinoma in a postmenopausal woman.

Xiu-Jie Yu1, Lin Zhang1, Zai-Ping Liu2, Yi-Quan Shi1, Yi-Xin Liu1.   

Abstract

Malignant germ cell tumors of the ovary are very rare and account for about 2-5% of all ovarian tumors of germ origin. Most patients are adolescent and young women, approximately two-thirds of them are under 20 years of age, occasionally in postmenopausal women. But clear cell carcinoma usually occurs in older patients (median age: 57-year old), and closely related with endometriosis. Here we report a case of a 55-year old woman with right ovarian mass that discovered by B ultrasonic. Her serum levels of human chorionic gonadotropin (hCG) and α-fetoprotein (AFP) were elevated. Pathological examination revealed the tumor to be a mixed germ cell tumor (yolk sac tumor, embryonal carcinoma and mature teratoma) with clear cell carcinoma in a background of endometriosis. Immunohistochemical staining showed SALL4 and PLAP were positive in germ cell tumor area, hCG, CD30 and OCT4 were positive in epithelial-like cells and giant synctiotrophoblastic cells, AFP, AAT, CD117 and Glyp3 were positive in yolk sac component, EMA and CK7 were positive in clear cell carcinoma, CD10 was positive in endometrial cells of endometriotic area. She was treated with surgery followed by seven courses of chemotherapy. She is well and serum levels of hCG and AFP have been decreased to normal levels.

Entities:  

Keywords:  Mixed germ cell tumor; clear cell carcinoma; ovary

Mesh:

Substances:

Year:  2014        PMID: 25674278      PMCID: PMC4313977     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  17 in total

1.  Ovarian endometrioid tumors with yolk sac tumor component, an unusual form of ovarian neoplasm. Analysis of six cases.

Authors:  F F Nogales; C Bergeron; R E Carvia; T Alvaro; H R Fulwood
Journal:  Am J Surg Pathol       Date:  1996-09       Impact factor: 6.394

2.  Ovarian cancer incidence in the United States, 1992-1999.

Authors:  Jeffrey T Quirk; Nachimuthu Natarajan
Journal:  Gynecol Oncol       Date:  2005-05       Impact factor: 5.482

Review 3.  A case of ovarian endometrioid adenocarcinoma with yolk sac tumor in a 35-year-old woman.

Authors:  D G Hong; G O Chong; W J Seong; Y S Lee; Y L Cho; J Y Park; J M Chae; I S Park
Journal:  Eur J Gynaecol Oncol       Date:  2010       Impact factor: 0.196

4.  [Mixed germ cell tumours of the ovary in childhood and adolescence].

Authors:  A Zuntová; D Sumerauer; L Teslík; E Kabícková; J Koutecký
Journal:  Cesk Patol       Date:  2004-07

5.  SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma.

Authors:  Dengfeng Cao; Shuangping Guo; Robert W Allan; Kyle H Molberg; Yan Peng
Journal:  Am J Surg Pathol       Date:  2009-06       Impact factor: 6.394

6.  Diagnostic utility of SALL4 in extragonadal yolk sac tumors: an immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alpha-fetoprotein, and glypican-3.

Authors:  Fenghua Wang; Aijun Liu; Yan Peng; Dinesh Rakheja; Lixin Wei; Debin Xue; Debing Xue; Robert W Allan; Kyle H Molberg; Jianping Li; Dengfeng Cao
Journal:  Am J Surg Pathol       Date:  2009-10       Impact factor: 6.394

7.  A case of ovarian endometrioid adenocarcinoma with a yolk sac tumor component.

Authors:  A Abe; H Furumoto; K Yoshida; M Nishimura; M Irahara; E Kudo; T Sano
Journal:  Int J Gynecol Cancer       Date:  2007-04-26       Impact factor: 3.437

8.  Ovarian mixed germ cell tumor composed of polyembryoma and immature teratoma.

Authors:  M Takemori; R Nishimura; M Yamasaki; Y Kawabe; K Hasegawa
Journal:  Gynecol Oncol       Date:  1998-06       Impact factor: 5.482

9.  Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group.

Authors:  S Williams; J A Blessing; S Y Liao; H Ball; P Hanjani
Journal:  J Clin Oncol       Date:  1994-04       Impact factor: 44.544

Review 10.  Recent concepts of ovarian carcinogenesis: type I and type II.

Authors:  Masafumi Koshiyama; Noriomi Matsumura; Ikuo Konishi
Journal:  Biomed Res Int       Date:  2014-04-23       Impact factor: 3.411

View more
  2 in total

1.  Clinicopathologic Characteristics and Survival of Patients with Rare Malignant Ovarian Yolk Sac Tumors: A Population-based Analysis.

Authors:  Tian Wang; Bo Wang; Shi-Xuan Wang; Ming-Fu Wu
Journal:  Curr Med Sci       Date:  2021-04-20

2.  Clinical features of a Chinese female nongestational choriocarcinoma cohort: a retrospective study of 37 patients.

Authors:  Yuming Shao; Yang Xiang; Fang Jiang; Boju Pan; Xirun Wan; Junjun Yang; Fengzhi Feng; Tong Ren; Jun Zhao
Journal:  Orphanet J Rare Dis       Date:  2020-11-18       Impact factor: 4.123

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.